Cannabis Bioscience International Holdings (CBIH) Total Debt (2023 - 2026)

Cannabis Bioscience International Holdings has disclosed Total Debt across 4 years of filings, most recently posting $264092.0 for Q1 2026.

• Total Debt for Q1 2026 came in at $264092.0, down 18.17% year-over-year; the trailing twelve-month figure through Feb 2026 was $264092.0 (down 18.17% YoY), and the FY2025 annual result was $264092.0, up 5.91% from the prior year.
• Total Debt came in at $264092.0 for Q1 2026 at Cannabis Bioscience International Holdings, roughly flat from $264092.0 in the prior quarter.
• In the past five years, Total Debt ranged from a high of $322729.0 in Q1 2025 to a low of $249361.0 in Q2 2024.
• The 4-year median for Total Debt is $264092.0 (2023), against an average of $265157.9.
• Across the five-year window, Total Debt rose 25.79% in 2025 and fell 18.17% in 2026, its largest moves.
• Cannabis Bioscience International Holdings' Total Debt stood at $261579.0 in 2023, then gained by 0.96% to $264092.0 in 2024, then changed by 0.0% to $264092.0 in 2025, then changed by 0.0% to $264092.0 in 2026.
• The last three Total Debt figures came in at $264092.0 (Q1 2026), $264092.0 (Q4 2025), and $249500.0 (Q3 2025), per Business Quant data.